高盛：中国生物制药_第 46 届全球医疗保健大会 —— 关键要点

12 June 2025 | 2:12PM HKT Sino Biopharmaceutical (1177.HK): 46th Annual Global Healthcare Conference — Key Takeaways Presenter: Kyler Lei - Head of Capital Markets Bottom Line: Management re-iterated guidance of double-digit sales growth for 2025, driven by 25% y/y growth of innovative drugs and positive growth from the generic portfolio de-risked from VBP impacts. With multiple innovative assets under active negotiations with MNC pharma and global leading biotech companies, the company highlighted one majo ...